Literature DB >> 28718411

Molecular Events in the Natural History of Pancreatic Cancer.

Leslie E Oldfield1, Ashton A Connor2, Steven Gallinger3.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest epithelial malignancies. Improvements in our understanding of PDAC carcinogenesis will hopefully improve its detection, management, and outcomes, as has been achieved with other malignancies. Here we review the literature on the natural history of PDAC, including its cell of origin, the initiating somatic mutational events, pathways deranged in the mature tumor, its biological heterogeneity, and the relationship of the primary tumor with metastases. We also suggest areas for further research and highlight translatable findings that are beginning to make clinical inroads.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  genomics; molecular biology; pancreatic cancer; review; transcriptomics

Mesh:

Year:  2017        PMID: 28718411     DOI: 10.1016/j.trecan.2017.04.005

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  26 in total

1.  The lncRNA-HOXA-AS2/EZH2/LSD1 oncogene complex promotes cell proliferation in pancreatic cancer.

Authors:  Yifan Lian; Zhaohua Li; Yanyun Fan; Qingwen Huang; Jianmin Chen; Wenming Liu; Chuanxing Xiao; Hongzhi Xu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 2.  Systematic appraisal of guidelines for the diagnosis of pancreatic cancer.

Authors:  Xin-Jie Liu; Ting Yang; Xin Shi; Bing-He Xiao; Li-Ya An; Su-Yun Zheng; Yu-Xing Qi; Da-Li Sun
Journal:  Gland Surg       Date:  2021-04

Review 3.  The role of lineage specifiers in pancreatic ductal adenocarcinoma.

Authors:  Soledad A Camolotto; Veronika K Belova; Eric L Snyder
Journal:  J Gastrointest Oncol       Date:  2018-12

4.  Keep Quiet and Stay in Line! Smart Polymers to Keep an Eye on Pancreatic Tumors.

Authors:  Pierre Cordelier
Journal:  Mol Ther       Date:  2018-03-19       Impact factor: 11.454

5.  Stereotactic Ablative Radiotherapy Using CALYPSO® Extracranial Tracking for Intrafractional Tumor Motion Management-A New Potential Local Treatment for Unresectable Locally Advanced Pancreatic Cancer? Results from a Retrospective Study.

Authors:  Hrvoje Kaučić; Domagoj Kosmina; Dragan Schwarz; Andreas Mack; Hrvoje Šobat; Adlan Čehobašić; Vanda Leipold; Iva Andrašek; Asmir Avdičević; Mihaela Mlinarić
Journal:  Cancers (Basel)       Date:  2022-05-29       Impact factor: 6.575

Review 6.  Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.

Authors:  Elvira Pelosi; Germana Castelli; Ugo Testa
Journal:  Biomedicines       Date:  2017-11-18

7.  Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression.

Authors:  Vincent Bernard; Alexander Semaan; Jonathan Huang; F Anthony San Lucas; Feven C Mulu; Bret M Stephens; Paola A Guerrero; Yanqing Huang; Jun Zhao; Nabiollah Kamyabi; Subrata Sen; Paul A Scheet; Cullen M Taniguchi; Michael P Kim; Ching-Wei Tzeng; Matthew H Katz; Aatur D Singhi; Anirban Maitra; Hector A Alvarez
Journal:  Clin Cancer Res       Date:  2018-11-01       Impact factor: 12.531

Review 8.  Drivers of Gene Expression Dysregulation in Pancreatic Cancer.

Authors:  Swati Venkat; Abdulrahman A Alahmari; Michael E Feigin
Journal:  Trends Cancer       Date:  2021-02-19

9.  Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting.

Authors:  Adham S Bear; Tatiana Blanchard; Joseph Cesare; Michael J Ford; Lee P Richman; Chong Xu; Miren L Baroja; Sarah McCuaig; Christina Costeas; Khatuna Gabunia; John Scholler; Avery D Posey; Mark H O'Hara; Anze Smole; Daniel J Powell; Benjamin A Garcia; Robert H Vonderheide; Gerald P Linette; Beatriz M Carreno
Journal:  Nat Commun       Date:  2021-07-16       Impact factor: 17.694

10.  H2A.Z overexpression suppresses senescence and chemosensitivity in pancreatic ductal adenocarcinoma.

Authors:  P A Ávila-López; G Guerrero; H N Nuñez-Martínez; C A Peralta-Alvarez; G Hernández-Montes; L G Álvarez-Hilario; R Herrera-Goepfert; J Albores-Saavedra; N Villegas-Sepúlveda; L Cedillo-Barrón; A E Montes-Gómez; M Vargas; M Schnoor; F Recillas-Targa; R Hernández-Rivas
Journal:  Oncogene       Date:  2021-02-24       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.